Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adi Vaknin

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Journal of Neuroimmunology|March 6, 2016
Differential screening-selected gene aberrative in neuroblastoma (DAN) is increased in the CSF of patients with MS and may be induced by therapy with interferon-βKarin Mausner-Fainberg, Hadar Kolb, Moran Penn, et al.
Journal of Neuroinflammation|April 27, 2021
Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107Tehila Mizrachi, Oshrit Marsha, Karen Brusin, et al.
The Journal of Spinal Cord Medicine|October 9, 2015
Effectiveness of multi-disciplinary rehabilitation for patients with Neuromyelitis OpticaYael Nechemia, Elior Moreh, Harold Weingarden, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 8, 2011
Robot-assisted gait training in multiple sclerosis patients: a randomized trialIsabella Schwartz, Anna Sajin, Elior Moreh, et al.
Multiple Sclerosis and Related Disorders|June 6, 2022
Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccineLivnat Brill, Ariel Rechtman, Alla Shifrin, et al.
Annals of Neurology|March 4, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with OcrelizumabLivnat Brill, Catarina Raposo, Ariel Rechtman, et al.
Journal of Neurology|March 26, 2024
Real-World experience with efgartigimod in patients with myasthenia gravisLior Fuchs, Shahar Shelly, Ifat Vigiser, et al.
Glia|August 23, 2023
Oligodendrocyte progenitor cells differentiation induction with MAPK/ERK inhibitor fails to support repair processes in the chronically demyelinated CNSTal Ganz, Omri Zveik, Nina Fainstein, et al.
Multiple Sclerosis and Related Disorders|October 6, 2023
Dual positivity for anti-MOG and oligoclonal bands: Unveiling unique clinical profiles and implicationsEsther Ganelin-Cohen, Shahar Shelly, Yael Schiller, et al.
Archives of Neurology|August 10, 2011
Myasthenia gravis-associated neuromyelitis optica-like disease: an immunological link between the central nervous system and muscle?Adi Vaknin-Dembinsky, Oded Abramsky, Panayiota Petrou, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Journal of Neuroimmunology|March 6, 2016
Differential screening-selected gene aberrative in neuroblastoma (DAN) is increased in the CSF of patients with MS and may be induced by therapy with interferon-βKarin Mausner-Fainberg, Hadar Kolb, Moran Penn, et al.
Journal of Neuroinflammation|April 27, 2021
Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107Tehila Mizrachi, Oshrit Marsha, Karen Brusin, et al.
The Journal of Spinal Cord Medicine|October 9, 2015
Effectiveness of multi-disciplinary rehabilitation for patients with Neuromyelitis OpticaYael Nechemia, Elior Moreh, Harold Weingarden, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 8, 2011
Robot-assisted gait training in multiple sclerosis patients: a randomized trialIsabella Schwartz, Anna Sajin, Elior Moreh, et al.
Multiple Sclerosis and Related Disorders|June 6, 2022
Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccineLivnat Brill, Ariel Rechtman, Alla Shifrin, et al.
Annals of Neurology|March 4, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with OcrelizumabLivnat Brill, Catarina Raposo, Ariel Rechtman, et al.
Journal of Neurology|March 26, 2024
Real-World experience with efgartigimod in patients with myasthenia gravisLior Fuchs, Shahar Shelly, Ifat Vigiser, et al.
Glia|August 23, 2023
Oligodendrocyte progenitor cells differentiation induction with MAPK/ERK inhibitor fails to support repair processes in the chronically demyelinated CNSTal Ganz, Omri Zveik, Nina Fainstein, et al.
Multiple Sclerosis and Related Disorders|October 6, 2023
Dual positivity for anti-MOG and oligoclonal bands: Unveiling unique clinical profiles and implicationsEsther Ganelin-Cohen, Shahar Shelly, Yael Schiller, et al.
Archives of Neurology|August 10, 2011
Myasthenia gravis-associated neuromyelitis optica-like disease: an immunological link between the central nervous system and muscle?Adi Vaknin-Dembinsky, Oded Abramsky, Panayiota Petrou, et al.
Pageof 9